A major international study has given scientists their clearest picture yet of the genetic changes behind colorectal cancer, one of the most common and deadly cancers worldwide.
Researchers say the findings could lead to more personalized treatments, earlier detection, and better outcomes for patients in the future.
The research was led by experts from several leading universities and cancer research centers in the United Kingdom, including The Institute of Cancer Research in London, the University of Oxford, and the University of Manchester. The findings were published in the journal Nature.
Colorectal cancer affects the colon and rectum, which are parts of the large intestine. It is one of the leading causes of cancer deaths around the world. The disease develops when cells in the lining of the colon or rectum begin growing uncontrollably after changes occur in their DNA.
DNA acts like an instruction manual inside cells. It controls how cells grow, divide, repair themselves, and eventually die. When harmful mutations appear in certain genes, cells can begin behaving abnormally and may eventually turn into cancer.
Although scientists have studied colorectal cancer for many years, they still did not fully understand all the genetic changes involved or why the disease behaves so differently from one patient to another. Some tumors grow slowly, while others spread aggressively. Some patients respond well to treatment, while others do not.
This new study provides one of the most detailed genetic maps of colorectal cancer ever created. Researchers analyzed genetic information from 2,023 colorectal cancer samples collected through the 100,000 Genomes Project.
This large national project was launched in England to study the genetic causes of diseases by sequencing the genomes of thousands of patients.
Using advanced genetic analysis, the scientists discovered more than 250 genes that appear to play important roles in colorectal cancer. Many of these genes had never before been connected to cancer.
Some of the newly identified genes seem to influence how cancer cells grow and survive. Others may help tumors avoid attacks from the immune system, while some appear to affect how cancers respond to certain drugs.
The researchers also found that colorectal cancer is not a single disease. Instead, it can be divided into several genetic subtypes. The team identified four major sub-groups of colorectal cancer, as well as several rare forms. Each subtype showed its own unique pattern of mutations.
This discovery is important because it may help explain why patients can have very different experiences with the disease. Some cancers may be more aggressive than others, while certain tumors may respond better to specific treatments.
Doctors hope that understanding the genetic makeup of each tumor could allow more personalized treatment plans in the future. Rather than giving every patient the same treatment, doctors may eventually be able to choose therapies based on the exact genetic profile of an individual tumor.
Another important finding involved differences between cancers in various parts of the colon and rectum. Researchers discovered that tumors in different locations often carried different genetic mutations. This may partly explain why colorectal cancer varies so much from person to person.
The scientists also identified a biological process that appeared more active in tumors from younger patients. Although researchers do not yet know the exact cause, they believe lifestyle and environmental factors may contribute. Diet, smoking, obesity, alcohol use, and other lifestyle habits are already known to influence colorectal cancer risk.
One particularly promising finding was that some of the genetic mutations discovered in colorectal cancer may already be targetable with drugs currently used for other types of cancer. This raises the possibility that some patients with colorectal cancer could benefit from treatments that were not originally designed for this disease.
Researchers say this could speed up the development of more effective therapies because some of these drugs are already approved and available.
The study also explored another growing area of cancer research: the gut microbiome. The gut microbiome is the enormous collection of bacteria, viruses, and other microorganisms living inside the digestive system.
Scientists are increasingly discovering that the microbiome may influence many aspects of human health, including digestion, immunity, mental health, and cancer development.
For the first time, the researchers performed detailed sequencing of the microbiomes of colorectal cancer patients alongside the tumors’ genetic information. This gave them a more complete picture of what may be happening inside the body during cancer development.
Although scientists are still learning how the microbiome affects cancer, the findings raise exciting possibilities for future treatments. One day, gut bacteria could potentially help doctors predict cancer risk, improve treatment responses, or even become part of new therapies.
Professor Ian Tomlinson from the University of Oxford, one of the lead researchers, said the study gives scientists a much deeper understanding of the genetic causes of colorectal cancer. He explained that these discoveries may help doctors choose more effective treatments and improve survival rates for patients.
Professor Richard Houlston from The Institute of Cancer Research said the findings provide important clues about how colorectal cancer develops and grows over time. Understanding these biological processes may eventually help researchers stop the disease earlier or prevent it from progressing.
Professor David Wedge from the University of Manchester described the study as one of the first major breakthroughs from the 100,000 Genomes Project. He said the project is expected to produce many more important discoveries about cancer and other diseases in the coming years.
Dr. Henry Wood from the University of Leeds added that combining tumor genetics with microbiome research allows scientists to better understand the complex environment surrounding cancer. This fuller picture may reveal entirely new ways to fight the disease.
Researchers believe the study could eventually improve how doctors predict cancer behavior, identify high-risk patients, and develop more targeted therapies. Personalized medicine, where treatment is tailored to an individual patient’s biology, is becoming one of the most important goals in cancer research.
Colorectal cancer remains a major global health challenge, but studies like this are helping scientists move closer to understanding the disease at its roots. By uncovering the hidden genetic and biological changes behind colorectal cancer, researchers hope to create better treatments and give patients a greater chance of survival.
If you care about cancer, please read studies about how to fight cancer with these anti-cancer superfoods ,and a berry that can prevent cancer, diabetes and obesity.
For more health information, please see recent studies about how to harness the power of anti-cancer foods and supplements, and cancer-fighting foods and recipes.
The research findings were published in the journal Nature.
Copyright © 2026 Knowridge Science Report. All rights reserved.
